All Articles

Elea Data Centers and AXIA Energia are building a landmark AI facility in Belém, powered entirely by renewables and poised to transform the Amazon's digital landscape.

As AI moves from experiment to a board-level imperative, CIOs face a 'scale or fail' moment. Info-Tech LIVE 2026 tackles the real challenge: execution.

A new report from Adobe's Semrush on 126M AI prompts shows brands are losing control of their narrative. Visibility is no longer about SEO, but about trust.

While May's headline delinquency numbers seem calm, a surge in serious defaults and foreclosures to multi-year highs reveals growing stress for homeowners.

Canada's new Safe Social Media Act imposes sweeping rules and massive fines on social media and AI firms. What does this mean for compliance and innovation?

Canada's flag carrier rolls out a patriotic summer campaign, but operational headwinds, airport chaos, and labor unease threaten a smooth landing.

A new report reveals AI engines now favor drugstore science over luxury prestige, signaling a tectonic shift in how brands are built and valued.

Ninepoint's new ETF offers a high-risk, high-reward path to investing in AI giant Anthropic, using leverage and options. Is this the future of AI investing?

Footprints Floors' new contest isn't just about a prize. It's a strategic move to leverage authentic customer stories as its most powerful marketing asset.

Star Therapeutics' innovative drug VGA039 lands a $2B deal with Incyte, signaling a major shift in treating the most common inherited bleeding disorder.

Elounda Hills' record sales reveal more than a hot property market; they signal Crete's transformation into a global hub, powered by new infrastructure and a new vision for luxury.

HCW Biologics executes a reverse stock split to avoid Nasdaq delisting. Is it a necessary survival tactic or a warning sign for investors? We analyze.

After years as a national embarrassment, 24 Sussex Drive is getting a lifeline. The plan is more than a renovation; it’s a strategic pivot to private funding.

Medicenna Therapeutics is advancing its promising cancer immunotherapies, MDNA11 and MDNA113, while navigating a tight financial runway. Can it deliver?

Maalexi just closed a $2.8M round led by Saudi's top insurer to build a regulated crypto exchange for crops. Is this the future of global food security?

FactSet's new AI tool promises to democratize portfolio analytics. But in a high-stakes industry, can it deliver powerful insights without sacrificing trust?

Lupin's generic approval for Xtandi isn't just about price. Its new single-pill dose could transform patient care and challenge Astellas's market dominance.

New research reveals that even with pensions, government workers need more. Financial guidance, digital tools, and literacy are key to true confidence.

Asia's largest home furnishing firm just launched an AI that designs entire homes in 30 minutes, linking plans directly to its massive robot factories.

reAlpha Mortgage is ditching traditional commissions for a flat-fee model with stock options and AI. A bold commercialization play in the war for loan officers.